BAM
VKTX icon

Bosun Asset Management’s Viking Therapeutics VKTX Stock Holding History

Bosun Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,145
Closed -$452K – 222
2024
Q3 		$452K Sell
7,145
-2,069
-22% -$121K 0.22% 122
2024
Q2 		$488K Sell
9,214
-5,244
-36% -$344K 0.29% 91
2024
Q1 		$1.19M Buy
+14,458
New +$643K 0.68% 40

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bosun Asset Management's VKTX Position: Q4 2024 in Review

Bosun Asset Management sold out of Viking Therapeutics (VKTX) in Q4 2024, closing a stake of 7,145 shares — an estimated $452K sold.

Bosun Asset Management first reported a position in VKTX in Q1 2024 and held it in 3 quarters. The position peaked at $1.19M in Q1 2024. 408 funds tracked by Wall St. Rank hold VKTX as of Q4 2024.

  • Bosun Asset Management reported no remaining Viking Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Bosun Asset Management sold 7,145 Viking Therapeutics shares in Q4 2024, an estimated $452K.
  • Bosun Asset Management first reported a position in Viking Therapeutics in Q1 2024 and held it in 3 quarters.
  • Bosun Asset Management's Viking Therapeutics position peaked at $1.19M in Q1 2024.
  • 408 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2024.

Based on Bosun Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.